Director bought
~$51KReported value · 6,400 sh @ $7.91
Stock since the trade +27.6% · S&P 500 +3.3% · to Oct 5
A board member of ADMA Biologics paid $51K out of pocket for ADMA Biologics shares.
Loading…
ADMA · NASDAQ · Biotechnology
Biotechnology company based in Ramsey, New Jersey.
In the last 90 days, no insider of ADMA Biologics, Inc. reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$10.11
Last 12 months
Not enough history
Market value
$2.26B
Revenue
$124M
+2.0% vs the same quarter a year earlier
Free cash flow, last 12 months
$116M
This quarter $27.3M, a year earlier $18.7M
Net debt
$60.6M
Debt $197M, cash $136M, at Jun 30, 2026
Net income, last 12 months
$169M
Operating profit covers interest 25.4x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 5, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$510M
+19.6% vs the year before
Net income, fiscal 2025
$147M
As reported in the annual filing
Shares outstanding
224M
As of Jul 31, 2026
In fiscal 2025 the company spent $31.9M buying back its own shares. Cash actually paid, from its cash-flow statement.
Stock since the trade +27.6% · S&P 500 +3.3% · to Oct 5
A board member of ADMA Biologics paid $51K out of pocket for ADMA Biologics shares.
Jerrold B Grossman · Traded May 11 – May 12, 2026 · largest single filing ~$100K
May 12, 2026~$100K · 13K sh @ $8.01
DetailsOfficial recordMay 11, 2026~$100K · 13K sh @ $8.01
DetailsOfficial recordCEO sold ~$227K of ADMA Biologics, Inc.
Scheduled in advanceCEO sold ~$91K of ADMA Biologics, Inc.
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $14.07 on Oct 6, 2025 to $10.11 on Oct 5, 2026 (-28.1%). Disclosed activity in the last 12 months: 5 insider purchases, 11 insider sales (11 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.